$3,850.00 – $5,850.00
Published on: January 20, 2023The global market for PEGylated proteins is expected to reach USD 1,617.3 million by 2025, rising between 2020 and 2025 at a CAGR of 9.21%. Growing R&D investment by pharmaceutical & biotechnology companies, growth in the biologics sector, high prevalence of lifestyle disease, growing emphasis on strategies to enhance protein stability and circulate half-life are the major drivers for the market.
1 Global PEGylated Proteins Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global PEGylated Proteins Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global PEGylated Proteins Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global PEGylated Proteins Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global PEGylated Proteins Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global PEGylated Proteins Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global PEGylated Proteins Market – By Product (Market Size – & million/billion)
8.1 Services
8.2 Consumables
9 Global PEGylated Proteins Market – By Protein Type
9.1 Colony Stimulating Factors
9.2 Interferons
9.3 Erythropoietin
9.4 mAbs
9.5 Recombinant Factor VIII
9.6 Other
10 Global PEGylated Proteins Market – By Application
10.1 Cancer Treatment
10.2 Hepatitis
10.3 Chronic Kidney Diseases
10.4 Hemophilia
10.5 Multiple Sclerosis
10.6 Gastrointestinal Disorders
10.7 Other
11 Global PEGylated Proteins Market – By End-User
11.1 Pharmaceutical & Biotechnology Companies
11.2 CROs
11.3 Academic Research Institutes
12 Global PEGylated Proteins Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global PEGylated Proteins Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global PEGylated Proteins Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Jenkem Technology
14.3 NOF American Corporation
14.4 Merck Millipore
14.5 Thermo Fisher Scientific Inc.
14.6 Iris Biotech GmbH
14.7 Biomatrik, Inc.
14.8 Quanta Biodesign, Ltd
14.9 Celares GmbH
14.10 Creative Pegworks
14.11 Laysan Bio, Inc.
14.12 Company 11 & more
15 Global PEGylated Proteins Market – Appendix
15.1 Sources
15.2 Abbreviations
